Bright Minds Biosciences Cash Flow Statement 2020-2024 | DRUG

Fifteen years of historical annual cash flow statements for Bright Minds Biosciences (DRUG).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
2023202220212020
$-5.47$-11.72$-6.85$0.00
$0.05$0.00$0$0
$0.90$0.51$0.81$0
$0.96$0.51$0.81$0
$0$0$0$0
$0$0$0$0
$0$0$0$0
$0.19$-0.03$-0.16$0
$-0.70$0.57$0.24$0
$-5.21$-10.64$-5.79$0
$0$0$0$0
$0$0$0$0
$0$0$0$0
$0$0$0$0
$0$0$0$0
$0$0$0$0
$0$0$0$0
$0$0$0$0
$0$0$0$0
$-0.06$-0.01$0$0
$-0.06$-0.01$0$0
$0.80$1.54$0.09$0
$0.80$1.54$0.09$0
$0$0$0$0
$0.88$2.53$20.53$0
$1.62$4.07$20.62$0
$-3.62$-6.37$15.01$0
$0.85$0.69$0.70$0
$0$0$0$0